Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
SNS-032 is a selective inhibitor of cyclin-dependent kinases (CDKs) that has shown potential as an anticancer agent. It has been studied in preclinical and clinical trials for its ability to inhibit the growth of cancer cells by blocking the activity of Cyclin-dependent kinases (CDKs), which are enzymes involved in cell cycle regulation. SNS-032 has demonstrated promising results in inhibiting the growth of various cancer types, including leukemia, lymphoma, and solid tumors.
…